Oak Ridge Investments LLC trimmed its position in shares of CME Group Inc (NASDAQ:CME) by 3.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 5,424 shares of the financial services provider’s stock after selling 165 shares during the quarter. Oak Ridge Investments LLC’s holdings in CME Group were worth $1,020,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently bought and sold shares of CME. Ruggie Capital Group purchased a new stake in shares of CME Group in the fourth quarter worth about $28,000. Smith Asset Management Group LP boosted its position in shares of CME Group by 200.0% in the fourth quarter. Smith Asset Management Group LP now owns 150 shares of the financial services provider’s stock worth $28,000 after buying an additional 100 shares during the period. Nelson Roberts Investment Advisors LLC purchased a new stake in shares of CME Group in the fourth quarter worth about $33,000. Athena Capital Advisors LLC purchased a new stake in shares of CME Group in the fourth quarter worth about $43,000. Finally, Ipswich Investment Management Co. Inc. purchased a new stake in shares of CME Group in the fourth quarter worth about $47,000. Institutional investors own 86.63% of the company’s stock.
Shares of CME Group stock opened at $181.91 on Friday. CME Group Inc has a fifty-two week low of $153.90 and a fifty-two week high of $197.08. The company has a current ratio of 1.01, a quick ratio of 1.09 and a debt-to-equity ratio of 0.15. The company has a market capitalization of $61.13 billion, a price-to-earnings ratio of 26.67, a P/E/G ratio of 2.25 and a beta of 0.30.
CME Group (NASDAQ:CME) last posted its quarterly earnings results on Thursday, February 14th. The financial services provider reported $1.77 earnings per share for the quarter, beating the consensus estimate of $1.75 by $0.02. The firm had revenue of $1.24 billion during the quarter, compared to the consensus estimate of $1.22 billion. CME Group had a net margin of 45.53% and a return on equity of 9.85%. The business’s revenue was up 37.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.12 earnings per share. Equities analysts anticipate that CME Group Inc will post 7.07 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Monday, March 25th. Stockholders of record on Friday, March 8th will be given a $0.75 dividend. The ex-dividend date is Thursday, March 7th. This represents a $3.00 annualized dividend and a dividend yield of 1.65%. This is a positive change from CME Group’s previous quarterly dividend of $0.70. CME Group’s payout ratio is 41.06%.
A number of brokerages recently commented on CME. BidaskClub raised CME Group from a “sell” rating to a “hold” rating in a report on Friday. Zacks Investment Research downgraded CME Group from a “buy” rating to a “hold” rating in a report on Friday, December 7th. Citigroup set a $205.00 price target on CME Group and gave the company a “buy” rating in a report on Friday, February 15th. Sanford C. Bernstein reissued an “outperform” rating and issued a $210.00 price target on shares of CME Group in a report on Friday, February 15th. Finally, Barclays initiated coverage on CME Group in a report on Tuesday, December 4th. They set an “overweight” rating and a $210.00 target price on the stock. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and seven have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $193.47.
In other CME Group news, insider Sean Tully sold 13,500 shares of the company’s stock in a transaction on Wednesday, December 12th. The shares were sold at an average price of $191.69, for a total value of $2,587,815.00. Following the completion of the transaction, the insider now directly owns 36,328 shares in the company, valued at approximately $6,963,714.32. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Jeffrey M. Bernacchi sold 10,087 shares of the company’s stock in a transaction on Tuesday, February 26th. The stock was sold at an average price of $177.94, for a total transaction of $1,794,880.78. Following the completion of the transaction, the director now owns 42,004 shares of the company’s stock, valued at $7,474,191.76. The disclosure for this sale can be found here. In the last three months, insiders sold 41,734 shares of company stock worth $7,775,309. Insiders own 0.43% of the company’s stock.
WARNING: “Oak Ridge Investments LLC Has $1.02 Million Position in CME Group Inc (CME)” was first reported by Fairfield Current and is the sole property of of Fairfield Current. If you are viewing this piece of content on another publication, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.fairfieldcurrent.com/news/2019/03/01/oak-ridge-investments-llc-has-1-02-million-position-in-cme-group-inc-cme.html.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Further Reading: Market Capitalization and Individual Investors